NCT07579754Recruiting
BetterInfo on Women's PrEP Choices and Outcomes in Malawi
BetterInfo Tracing Approach to Evaluate HIV PrEP Choices and Use Over Time Among Women in Blantyre, Malawi
Source: ClinicalTrials.gov · Last updated 15 Jul 2026
Brief summary (registry, in English)
The purpose of this study is to understand PrEP user choices, preferences and implementation impact of the roll-out of long-acting injectable PrEP alongside oral PrEP among women in Blantyre, Malawi.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 384 (estimated)
- First submitted
- 30 Apr 2026
- Start date
- 14 Jul 2026
- Primary completion date
- 30 Apr 2028
- Lead sponsor
- Johns Hopkins Bloomberg School of Public Health
- Diseases
- HIV
- NCT number
- NCT07579754
What you commit to
- Study type: Interventional
- Planned participants: 384
- From 14 Jul 2026 to the primary completion date, 30 Apr 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Those excluded from sampling or tracing include:
- Women who have an EMR record of a documented case of discontinuation of PrEP in consultation with a provider; or
- Women who are known to have died; or
- Women who have EMR documented transfers out of PathToScale supported facilities; or
- Women refusing follow-up via phone on their ScanForm; or
- Women refusing follow-up in person (during phone tracing); or
- Women who do not speak Chichewa or English; or
- Men (excluded from client interviews only)
Who the study is looking for
- The population for this research includes women aged 18 years or older at risk of HIV who initiated injectable or oral PrEP at one of the 20 Blantyre sites supported through PathToScale. PathToScale supports various types of facilities including public health clinics, drop-in centers for prioritized populations (DICs), and private hospitals/clinics.
- Those eligible for sampling are as follows:
- Adult women ≥18 years; and
- Initiated PrEP (injectable or oral) at the implementing facilities and lost to follow up within prior 2 years prior to sampling; and
- Lost-to-follow-up (missed their PrEP visit by ≥3 months and for whom outcomes are unknown); and
- Has a registered phone number for contact
- Those eligible for tracing are as follows:
- Women sampled per eligibility criteria above; and
- Women who have indicated permission for in-person follow-up
- Health Care Providers, Implementing Partners, Ministry of Health (MOH) Stakeholers
- providers and implementing partners from PathtoScale, and Ministry of Health stakeholders will be consented to participate in in-depth-interviews
Age in the registry: 18 years to 110 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Johns Hopkins Research Project Malawi Coordinator of this site? Confirm its status | Blantyre | Malawi | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.